Theravance Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2014
Total Assets: $337.8M
Liabilities Breakdown FY2014
Total Liabilities: $48.0M
Asset Breakdown
Total Assets: $337.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $89.2M | 26.4% |
| Accounts Receivable | $289.0K | 0.1% |
| Inventory | $12.5M | 3.7% |
| Property, Plant & Equipment | $9.7M | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $226.1M | 66.9% |
Liabilities Breakdown
Total Liabilities: $48.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.9M | 20.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.1M | 79.3% |